SCHEMBL12378712

SCHEMBL12378712

CNC(=O)c1c2c(c(O)c3ncc(Cc4ccc(C)cc4)cc13)C(=O)N(C)C2

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.34
NPC1 O15118 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 2/20 0.32
GAA P10253 1/20 0.32
EGLN1 Q9GZT9 2/20 0.31
KDM5A P29375 1/20 0.31
TP53 P04637 1/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
BCL2L1 Q07817 1/20 0.30
BRD4 O60885 1/20 0.30
CXCR3 P49682 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12378399 0.92 LIPG (0.36) LIPGSMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL12378692 0.90 BCL2L1 (0.31) LIPGNPC1SMN1; SMN2MAPTL3MBTL1
SCHEMBL12378709 0.89 PREP (0.34) LIPGNPC1SMN1; SMN2MAPTL3MBTL1
SCHEMBL12378719 0.89 CNR2 (0.38) LIPGNPC1SMN1; SMN2MAPTL3MBTL1
SCHEMBL12378702 0.88 TACR1 (0.33) LIPGKDM5ABCL2L1
SCHEMBL12378698 0.88 KIT (0.30)
SCHEMBL12378717 0.86 PREP (0.33) LIPGNPC1SMN1; SMN2MAPTL3MBTL1
SCHEMBL12378714 0.86 LIPG (0.35) LIPGNPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL12378695 0.86
SCHEMBL12378696 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008287-B2 Use treating HIV and AIDS; tricyclic compounds such as those based on 5-sulfonamido-9-hydroxy-6,8-dihydrdo-7H-pyrrolo[3,4-g]quinoline-8-one GILEAD SCIENCES, INC. (US) 2011-08-30 US disclosed